华北制药：上半年归母净利润1.23亿元，同比增长71.56%

Group 1 - The company reported a revenue of 5.275 billion yuan for the first half of 2025, representing a year-on-year growth of 0.84% [1] - The net profit attributable to shareholders of the listed company was 123 million yuan, showing a significant year-on-year increase of 71.56% [1] - The basic earnings per share were 0.072 yuan [1]